SavedAdd your journal

Journals / Journal of Experimental and Clinical Medicine / 2026 / Volume: 42 Issue: 2

Posterior reversible encephalopathy syndrome in pregnancy: A case report with review literature

Emel Çağlayan(tekirdağ namık kemal university)0000-0002-4290-6412
Hadi Sasanı(TEKIRDAG NAMIK KEMAL UNIVERSITY)0000-0001-6236-4123
Pages
—
Publication Date
2025-06-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Treatment is available before a lasting neurological disability arises with an early diagnosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Posterior reversible encephalopathy (PRES) is an uncommon condition that causes edema in the white matter of the posterior fossa of the brain along with headache, altered consciousness, visual impairment, and occasionally seizures.
📊
Key Findings & Data:The diagnosis and course of treatment for a PRES case involving a patient who was 24 weeks pregnant are discussed in this article along with relevant literature.A 21-year-old patient who was 24 weeks pregnant suddenly lost her vision, had high blood pressure, hemolysis, raised liver enzymes, low platelet count, and an emergency cesarean section was used to deliver the baby.
💡
Conclusion & Impact:Treatment is available before a lasting neurological disability arises with an early diagnosis.
🔬Design:Case Report
📍Scope:Comprehensive Sample
⚙️Variables:Posterior reversible encephalopathy · Pregnancy · neurological symptom

Abstract

Posterior reversible encephalopathy (PRES) is an uncommon condition that causes edema in the white matter of the posterior fossa of the brain along with headache, altered consciousness, visual impairment, and occasionally seizures. The diagnosis and course of treatment for a PRES case involving a patient who was 24 weeks pregnant are discussed in this article along with relevant literature.A 21-year-old patient who was 24 weeks pregnant suddenly lost her vision, had high blood pressure, hemolysis, raised liver enzymes, low platelet count, and an emergency cesarean section was used to deliver the baby. Magnetic resonance imaging (MRI) in the early postoperative phase showed vasogenic edema in the occipito-parietal region's white matter. In addition to antihypertensive drugs and cortisol, the patient received intravenous (IV) hydration treatment. She was discharged on the 10th postoperative day with his complaints and laboratory values within normal limits. In the existence of neurological symptoms in PRES disease, strong suspicion, and brain imaging are required for early diagnosis. Treatment is available before a lasting neurological disability arises with an early diagnosis.

🔖

Cite This Article

Çağlayan, E., Sasanı, H. (2025). Posterior reversible encephalopathy syndrome in pregnancy: A case report with review literature. Journal of Experimental and Clinical Medicine, Volume: 42 Issue: 2. https://ajindex.com/articles/1422600

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (19)

  1. Makouei M, Hartup LA, Neohoff BK, Boyd AR,Daftaribesheli L, Mirmoeeni S, et al. The pathophysiologic, diasnostic, and therapeutic aspects of posterior reversible encephalopathy syndrome during pregnancy.J Maternity fetal neonatal med. 2022;35(25):8735- 8743 doi:10.1080/1477058.2021.2001454
  2. Chaudhuri J, Basu S, Roy MK, Chakravarty A. Posterior reversible Leucoencephalopathy Syndrome: Case Series, Comments, and Diagnostic Dilemma. curr neurol Neurosci Rep. 2023;23(8):433- 449 doi:10.1007/s11910-023-01281-3
  3. Singhal AB. posterior reversible encephalopathy Syndrome oath reversible cerebral vasocon striction Syndrome as Syndromes of Cerebrovascular Dysregulation. Continuum ( Minneap Minn ) 2021;27 (5):1301-1320 doi:10.1212/CON.0000000000001037
  4. Shankar J, Banfield J. Posterior reversible Encephalopathy: A Review Can Assoc Radiol J. 2017;68(2):147-153 doi:10.1016/j.carj.2016.08.005
  5. Murali S, Miller K, McDermott M. Preeclampsia, eclampsia, and posterior reversible encephalopathy syndrome. Handb Clin Neurol.2020;172:3-77 Doi:10.1016/B978-0-444-64240-0.00004-0
  6. Triplett JD, Kutlubaev MA,Kermode AG,Hardy T. Posterior reversible encephalopathy syndrome (PRES): diagnosis oath management. Pract Neurol.2022;22(3):183-189.Doi:10.1136/practneurol-2021-003194
  7. Shaikh N, Nawaz S, Ummunisa F, Shahzad A, Hussain J, Ahmad K, et al. Eclampsia and posterior reversible encephalopathy syndrome (PRES): A retrospective review of risk factors oath outcomes. Qatar Med J.2021;2021(1):4 doi:10.5339/qmj.2021.4.eCollection2021
  8. Li Y, Song J, Huq AM, Timilsina S, Gershmin ME. posterior reversible encephalopathy syndrome oath autoimmunity. Autoimmun Rev.2023;22(2):103239 doi:10.101/.autrev.2022.103239
  9. Çimen Güneş E, Çolak S, Tekgöz E, Çınar M, Yılmaz S. Golimumab-induced posterior reversible encephalopathy syndrome (PRES):a case-based review.Clin Rheumatol.2023;42(12):3407-3410 doi:10.1007/s10067-023-06771-w
  10. Verhaegen J,Peeters F, Debois F, Jacquemyn Y. Pesterior reversible encephalopathy syndrome as a complication of pre-eclamsia in the early postpartum period. BMJ Case Rep.2019;12(7):e228954 doi:10.113/bcr-2018-228954
  11. Makouei M, Hartup LA, Neohoff BK, Boyd AR,Daftaribesheli L, Mirmoeeni S, et al. The pathophysiologic, diasnostic, and therapeutic aspects of posterior reversible encephalopathy syndrome during pregnancy.J Maternity fetal neonatal med. 2022;35(25):8735- 8743 doi:10.1080/1477058.2021.2001454
  12. Chaudhuri J, Basu S, Roy MK, Chakravarty A. Posterior reversible Leucoencephalopathy Syndrome: Case Series, Comments, and Diagnostic Dilemma. curr neurol Neurosci Rep. 2023;23(8):433- 449 doi:10.1007/s11910-023-01281-3
  13. Singhal AB. posterior reversible encephalopathy Syndrome oath reversible cerebral vasocon striction Syndrome as Syndromes of Cerebrovascular Dysregulation. Continuum ( Minneap Minn ) 2021;27 (5):1301-1320 doi:10.1212/CON.0000000000001037
  14. Shankar J, Banfield J. Posterior reversible Encephalopathy: A Review Can Assoc Radiol J. 2017;68(2):147-153 doi:10.1016/j.carj.2016.08.005
  15. Murali S, Miller K, McDermott M. Preeclampsia, eclampsia, and posterior reversible encephalopathy syndrome. Handb Clin Neurol.2020;172:3-77 Doi:10.1016/B978-0-444-64240-0.00004-0
  16. Triplett JD, Kutlubaev MA,Kermode AG,Hardy T. Posterior reversible encephalopathy syndrome (PRES): diagnosis oath management. Pract Neurol.2022;22(3):183-189.Doi:10.1136/practneurol-2021-003194
  17. Shaikh N, Nawaz S, Ummunisa F, Shahzad A, Hussain J, Ahmad K, et al. Eclampsia and posterior reversible encephalopathy syndrome (PRES): A retrospective review of risk factors oath outcomes. Qatar Med J.2021;2021(1):4 doi:10.5339/qmj.2021.4.eCollection2021
  18. Li Y, Song J, Huq AM, Timilsina S, Gershmin ME. posterior reversible encephalopathy syndrome oath autoimmunity. Autoimmun Rev.2023;22(2):103239 doi:10.101/.autrev.2022.103239
  19. Verhaegen J,Peeters F, Debois F, Jacquemyn Y. Pesterior reversible encephalopathy syndrome as a complication of pre-eclamsia in the early postpartum period. BMJ Case Rep.2019;12(7):e228954 doi:10.113/bcr-2018-228954